3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
4
Erectile Dysfunction
2
Urogenital Neoplasms
1
Sexual Dysfunction, Physiological
1
Interventions
padeliporfin
3
Mitomycin
2
valrubicin
1
temsirolimus
1
pembrolizumab
1
palladium-bacteriopheophorbide
1
enfortumab vedotin
1
abiraterone
1
abemaciclib
1
Tadalafil
1
Standard of Care
1
Radiation Dose Hypofractionation
1
Prednisone
1
Prednisolone
1
Phosphodiesterase 5 Inhibitors
1
Gemcitabine
1
Fluorouracil
1
Drug Therapy
1
Cisplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Urogenital Neoplasms
×
Tadalafil
×
Clear all
NCT06717711
2024-12-05
RCT_LiESWT
Regina Elena Cancer Institute
Phase 3
Recruiting
158 enrolled